Webflow Homepage
Veterinarians
Services For
Canine lymphoma & Leukemia
Personalized Prediction Profile
AI-Driven Drug Response Predictions
(Flow Cytometry + PARR included)
Drug Response Predictions
NEW
Personalize anticancer drug treatment decisions with confidence
Immunoprofile
Get accurate diagnostic support from the start (Flow Cytometry + PARR)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Multidrug Sensitivity Genotyping (MDR1)
Identify MDR1 carrier status with ease
Digital Cytology (Add-on)
Confirm lymphoma or leukemia with precision
Services For
FELINE lymphoma & Leukemia
Immunoprofile
Get accurate diagnostic support from the start (PARR + Flow Cytometry)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Digital Cytology (Add-on)
Confirm lymphoma or leukemia with precision
for
veterinarians
Order Services via Vet Portal
Request Pricing
Clinical Case Studies
Our Science & Publications
Participate in Our Research
💖 Wall of Love: Customer Reviews
Veterinary Cancer Pioneers Podcast
Contact Us
Pet Parents
LEARN
How It Works
Dog Lymphoma 101
Cat Lymphoma 101
Our Science & Publications
Blog
Content Library
Get Started
Find a Veterinary Oncologist
Talk to Your Veterinarian
Customer stories & Case Studies
ImpriMed Reviews
Discover what other pet parents are saying and how oncologists use ImpriMed's reports
Human Oncology
CRO
Company
Company
Our Science & Publications
About Us
Careers
Events
Press
Contact Us
Contact Us
Other Links
ImpriMed Korea
Pricing
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Find a Vet
Get Started
Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
In the News
Health Tech: Valerie Goodwin-Adams of ImpriMed On How Their Technological Innovations Will Shake Up The Tech Scene
Authority Magazine
Learn More →
Presentations
Quantitative ex vivo synergy profiling uncovers heterogeneous combination responses in AML primary samples
67th ASH Annual Meeting and Exposition
Learn More →
Presentations
Ex vivo drug sensitivity testing in Korean AML patients: Integration of functional and genomic profiles for predicting clinical response and survival
67th ASH Annual Meeting and Exposition
Learn More →
Presentations
A multi-institutional machine-learning score that predicts bacteremia and gram class at blood-culture initiation
67th ASH Annual Meeting and Exposition
Learn More →
Press Releases
ImpriMed to Present Ex Vivo Drug Sensitivity Data in Acute Myeloid Leukemia in Oral Presentation at American Society of Hematology Annual Meeting
PR Newswire
Learn More →
Press Releases
ImpriMed Accelerates Growth With Strategic Leadership Hire and Major Operational Milestones
Business Wire
Learn More →
Presentations
Large-Scale Validation of a Flow Cytometry Platform for Comprehensive Immunophenotyping, Cell Size Determination, and Prognostic Stratification in Canine Lymphomas
Veterinary Cancer Society Annual Conference 2025
Learn More →
Presentations
Lumps, Lab Work, and a Little AI: A Tech’s Guide to Canine Lymphoma
Veterinary Cancer Society Annual Conference 2025
Learn More →
Presentations
When AI Disappoints: Improving Outcomes with Real-World Clinical Data
Veterinary Cancer Society Annual Conference 2025
Learn More →
Presentations
Ethos Discovery Stratified Outcomes for Lymphoma in Dogs (SOLID) Study: Informing Subclassification & Prognosis
ACVIM Forum 2025
Learn More →
Scientific Publications
Identification of novel genetic mutations for the treatment prognostication of canine lymphoma
npj Precision Oncology
Learn More →
Presentations
Chemotherapy selection for advanced or metastatic pancreatic cancer using machine learning models trained with multi-center datasets
2025 ASCO Gastrointestinal Cancers Symposium
Learn More →
Presentations
Optimizing the first line therapy of canine B-cell lymphomas via machine learning
Symposium on Artificial Intelligence in Veterinary Medicine (SAVY) 2.0
Learn More →
In the News
How Artificial Intelligence Is Revolutionising Cancer Care for Pets
Pets Magazine
Learn More →
Video/Podcast Interviews
AI, Cancer & the Future of Pet Care with Dr Ilona Holcomb
The Pets Mag Podcast
Learn More →
Presentations
A study on the relationship between ex vivo drug sensitivity and clinical outcome of acute lymphoblastic leukemia
AACR Special Conference in Cancer Research: Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals
Learn More →
In the News
Artificial Intelligence Takes on Cancer: The Only AI Dr. Karyn Doesn’t Hate
Dogster
Learn More →
In the News
Comparative Oncology: Advances in Cancer Care from Pets to Humans
Pharmacy Times
Learn More →
Next
